Esru® 40
Esomeprazole
Esru (Esomeprazole Magnesium) is a proton pump inhibitor (PPI) and the S-isomer of omeprazole, formulated as enteric-coated, delayed-release tablet/capsule pellets to protect the drug from stomach acid and allow intestinal release. It suppresses gastric acid secretion by irreversibly inhibiting the H⁺/K⁺-ATPase (proton pump) in gastric parietal cells, providing effective acid control for conditions such as GERD/erosive esophagitis, peptic ulcer disease (including NSAID-associated ulcers), and as part of H. pylori eradication regimens.
Product Specifications
| Therapeutic Class | Proton pump inhibitors |
| Dosage Form | Capsule |
| Strength | 40 mg |
| Composition | Esru 40 capsule: Each capsule contains enteric coated pellets of Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 40 mg. |
| Pack Sizes | Esru 20 tablet : Box containing 5 X 14 tablets in Alu-Alu blister pack. Esru 20 capsule : Box containing 10 X 10 Capsules in Alu-Alu blister pack. Esru 40 capsule : Box containing 6 X 10 Capsules in Alu-Alu blister pack. |
Detailed Information
Esru is indicated for the treatment of the following diseases: 1. Gastric ulcer, 2. Duodenal ulcer, 3. Erosive Esophagitis, 4. Long-term management of esophagitis, 5. Symptomatic Gastroesophageal Reflux Disease (GERD), 6. H. pylori eradication for treatment of Duodenal Ulcer. (Triple Therapy with Esomeprazole, Clarithromycin and Amoxicillin), 7. NSAID-induced peptic ulcers